V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10457815 | 10034715 | 1.58 | 81 | Curative (C) | null | 2018-09-04 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101702845 |
| 10457832 | 10034716 | 1.62 | 86.7 | Palliative (P) | 2016-09-21 | 2016-09-23 | Rituximab | N | N | RITUXIMAB | 100973423 |
| 10457845 | 10034717 | 1.66 | 90 | Adjuvant (A) | 2017-12-26 | 2018-01-04 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101262606 |
| 10457848 | 10034718 | 1.69 | 96.8 | Palliative (P) | 2016-11-15 | 2016-12-31 | IBRUTINIB | 02 | N | IBRUTINIB | 100385012 |
| 10457863 | 10034719 | 0 | 0 | Adjuvant (A) | 2019-03-19 | 2019-04-03 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 101174222 |
| 10457879 | 10034720 | 1.63 | 85.9 | null | 2019-01-19 | 2020-03-05 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101787312 |
| 10457918 | 10034721 | 1.77 | 68.8 | null | 2018-05-10 | 2018-05-10 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100924309 |
| 10457922 | 10034722 | 1.62 | 121 | Curative (C) | 2016-12-01 | 2018-06-01 | IBRUTINIB | 02 | null | IBRUTINIB | 100272795 |
| 10457970 | 10034723 | 1.63 | 68.95 | null | 2019-03-12 | 2019-06-04 | IBRUTINIB | 02 | null | IBRUTINIB | 101405081 |
| 10458025 | 10034724 | 1.69 | 86 | Palliative (P) | 2017-10-01 | 2017-10-14 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100352777 |
| 10458035 | 10034725 | 1.7 | 55.1 | Adjuvant (A) | 2020-01-25 | 2020-01-25 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100201628 |
| 10458053 | 10034726 | 1.77 | 96.4 | Palliative (P) | 2019-09-07 | 2019-09-07 | Capecitabine | 02 | N | CAPECITABINE | 100582712 |
| 10458060 | 10034727 | 1.67 | 82.8 | Palliative (P) | 2020-12-25 | 2020-12-26 | Rituximab | 02 | null | RITUXIMAB | 100301915 |
| 10458065 | 10034728 | 1.76 | 95 | Palliative (P) | 2016-12-29 | 2017-03-10 | Docetaxel | 02 | N | DOCETAXEL | 100758959 |
| 10458080 | 10034729 | 1.54 | 60 | Palliative (P) | 2019-02-21 | 2019-02-21 | Rituximab | 02 | N | RITUXIMAB | 100334364 |
| 10458103 | 10034730 | 1.52 | 84.2 | Palliative (P) | 2015-09-07 | 2015-09-09 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100978730 |
| 10458133 | 10034731 | 1.59 | 89.4 | Neo-adjuvant (N) | 2017-10-04 | 2017-10-16 | Docetaxel | 02 | null | DOCETAXEL | 100730996 |
| 10458158 | 10034732 | 1.55 | null | Curative (C) | 2017-05-28 | 2017-06-23 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100803937 |
| 10458175 | 10034733 | 1.82 | 110 | Palliative (P) | 2017-03-18 | 2017-04-14 | IBRUTINIB | 02 | N | IBRUTINIB | 100764831 |
| 10458177 | 10034734 | 1.52 | 68.75 | null | 2016-04-16 | 2016-04-18 | Capecitabine | 02 | null | CAPECITABINE | 100448931 |
| 10458181 | 10034735 | 1.59 | 82.3 | Palliative (P) | 2017-04-18 | 2017-04-18 | PEMBROLIZUMAB | 2 | N | PEMBROLIZUMAB | 100961231 |
| 10458189 | 10034736 | 1.62 | 85 | Palliative (P) | 2018-07-17 | 2018-07-18 | Rituximab | 02 | N | RITUXIMAB | 100203460 |
| 10458191 | 10034737 | 1.72 | 72 | Disease modification (D) | 2018-10-26 | 2018-11-13 | Capecitabine | 02 | N | CAPECITABINE | 101494867 |
| 10458194 | 10034738 | 1.83 | 86 | null | 2020-08-31 | 2020-09-27 | IBRUTINIB | 02 | null | IBRUTINIB | 101280862 |
| 10458198 | 10034739 | 1.57 | null | Palliative (P) | 2018-10-21 | 2018-10-21 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101367840 |
| 10458207 | 10034740 | 1.82 | null | 03 | null | 2017-03-13 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101474211 |
| 10458214 | 10034741 | 1.66 | 57 | null | 2018-07-27 | 2018-08-07 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101852984 |
| 10458230 | 10034742 | 1.93 | 68.6 | null | 2019-11-09 | 2019-11-30 | CAPECITABINE + OXALIPLATIN | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101062847 |
| 10458238 | 10034743 | 1.78 | 69 | Curative (C) | 2018-12-30 | 2019-01-22 | Capecitabine + Oxaliplatin 14day | 02 | N | CAPECITABINE | 100235084 |
| 10458252 | 10034744 | 1.82 | 71.5 | Palliative (P) | 2017-07-19 | 2017-07-21 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101602522 |
| 10458256 | 10034745 | 0 | 63.2 | Adjuvant (A) | 2018-07-05 | 2018-07-05 | IBRUTINIB | 02 | N | IBRUTINIB | 100033278 |
| 10458265 | 10034746 | 1.72 | 65.3 | Curative (C) | 2019-09-05 | 2019-09-05 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100717468 |
| 10458274 | 10034747 | 1.79 | 0 | null | 2021-05-26 | 2021-05-26 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 101542796 |
| 10458294 | 10034748 | 1.51 | 89 | Palliative (P) | 2019-06-27 | 2019-06-27 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100621966 |
| 10458297 | 10034749 | 1.72 | 82 | Curative (C) | 2020-12-25 | 2021-01-10 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 101839220 |
| 10458318 | 10034750 | 1.58 | 80.9 | Adjuvant (A) | 2020-09-30 | 2020-10-04 | Capecitabine | 02 | N | CAPECITABINE | 101052430 |
| 10458348 | 10034751 | 1.65 | 80 | Palliative (P) | 2019-06-30 | 2019-07-10 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100625521 |
| 10458358 | 10034752 | 1.57 | 58.6 | null | 2021-01-20 | 2021-03-09 | Rituximab | 02 | null | RITUXIMAB | 101726206 |
| 10458361 | 10034753 | 1.7 | 74.4 | null | 2017-04-02 | 2017-04-02 | CHOP R | 99 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100779255 |
| 10458364 | 10034754 | 1.69 | 74.8 | Palliative (P) | 2019-04-01 | 2019-04-12 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 100057086 |
| 10458421 | 10034755 | 1.89 | 70.6 | Palliative (P) | 2015-08-12 | 2015-08-12 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100304232 |
| 10458422 | 10034756 | 1.7 | 77.6 | 03 | 2016-09-07 | 2016-09-10 | Capecitabine + Oxaliplatin 21day | 02 | Y | DOCETAXEL | 101651964 |
| 10458446 | 10034757 | 1.75 | 80.6 | Curative (C) | 2022-04-05 | 2022-04-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100884435 |
| 10458452 | 10034758 | 1.71 | 86 | null | 2022-03-09 | 2022-03-19 | CAPECITABINE + OXALIPLATIN | 02 | null | IBRUTINIB | 100196329 |
| 10458477 | 10034759 | 1.74 | 83.6 | null | 2020-10-12 | 2021-10-21 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100156972 |
| 10458482 | 10034760 | null | 73.8 | Curative (C) | 2016-07-01 | 2016-07-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101148496 |
| 10458483 | 10034761 | 1.67 | 66 | Curative (C) | 2016-07-04 | 2016-07-13 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101485118 |
| 10458485 | 10034762 | 1.82 | 71 | Neo-adjuvant (N) | 2016-12-13 | 2017-01-08 | IBRUTINIB | 02 | N | IBRUTINIB | 100695209 |
| 10458491 | 10034763 | 1.67 | 59.4 | null | 2019-02-28 | 2019-02-28 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 100455241 |
| 10458493 | 10034764 | 1.85 | 146.9 | 03 | 2017-12-03 | 2017-12-18 | Docetaxel | 02 | N | DOCETAXEL | 100057962 |